Precision Biosensor (335810) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Precision Biosensor (335810) reported revenue of 19.9 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202519.9 billion KRW-5.4 billion KRW-10.0 billion KRW[source]
202419.1 billion KRW-5.4 billion KRW-7.3 billion KRW[source]
202320.4 billion KRW-4.8 billion KRW-4.5 billion KRW[source]
202220.5 billion KRW-4.5 billion KRW-6.8 billion KRW[source]
202115.9 billion KRW-4.3 billion KRW-4.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202556.6 billion KRW19.0 billion KRW37.6 billion KRW[source]
202454.3 billion KRW24.8 billion KRW29.6 billion KRW[source]
202362.3 billion KRW28.8 billion KRW33.5 billion KRW[source]
202256.1 billion KRW23.5 billion KRW32.6 billion KRW[source]
202153.9 billion KRW16.6 billion KRW37.2 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
2025-1.5 billion KRW-4.9 billion KRW8.0 billion KRW[source]
2024-1.4 billion KRW5.6 billion KRW-5.0 billion KRW[source]
2023-2.0 billion KRW-9.9 billion KRW6.7 billion KRW[source]
2022-2.6 billion KRW142 million KRW4.2 billion KRW[source]
2021-4.6 billion KRW-29.2 billion KRW17.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-30 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · EPS, DPS, and dividend yield are DART disclosure values. PER is calculated as closing price / disclosed EPS · This page provides factual information, not investment advice